Women in trials – no fooling!
April 1 might be April Fool’s Day, but it was also the day that the National Women’s Health Network spoke at a Food and Drug Administration (FDA) meeting on a topic that’s no joke -- the inclusion of women and people of color in clinical trials.
This issue goes to the heart of the NWHN’s mission of improving the health of all women. We urged the FDA to develop a rigorous action plan that will require companies to include women and people of color in clinical trials, evaluate drugs and medical devices based on sex, race and ethnicity, and include these analyses on product labels so that people can get the information. We called on the agency to reject applications from companies that fail to comply with these inclusion standards.
Add your voice to ours and tell the FDA to put women – and data in the picture!
Women lead the way
More than 7 million people enrolled in private health insurance plans through the new marketplaces, and more than half of them were women. That's more than 3.5 million women with new health insurance. And it’s a confirmation of the success of the work we've done through our Raising Women’s Voices for the Health Care We Need initiative! Learn more about how to help women get affordable coverage that makes it possible to get the care they need here.